BioAffinity Technologies Inc (NASDAQ:BIAF) does about 15.74M shares in volume on a normal day but saw 1986388 shares change hands in the recent trading day. The company now has a market cap of 8.17M USD. Its current market price is $0.29, marking a decrease of -2.97% compared to the previous close of $0.3. The 52 week high reached by this stock is $2.99 whilst the lowest price level in 52 weeks is $0.16.
The consensus objective for the share price is $6.00, suggesting that the stock has a potential upside of 95.17% over the period.
The current price level is 3.35%, -9.07%, and -66.79% away from its SMA20, SMA50, and SMA200 respectively, with the BIAF price moving above the 50-day SMA on current market day. BioAffinity Technologies Inc (BIAF) stock is up 24.76% over the week and -14.70% over the past month. Its price is -84.88% year-to-date and -68.44% over the past year.
The company’s next earnings report forecasts estimating quarterly EPS at -0.1 and -0.4 for whole year. Expected sales for next quarter are $1.55M, which analysts say will come at $6.5M for the current fiscal year and next year at $7.8M. In addition, estimates put the company’s current quarterly revenue at an average of $1.51M.
To reach the target analysts have set, the stock logically needs to grow 95.17 percent from here.
Outstanding shares total 28.46M with insiders holding 24.53% of the shares and institutional holders owning 1.80% of the company’s common stock. The company has a return on investment of -456.80% and return on equity of -290.85%. The beta has a value of 2.56. Price to book ratio is 3.64 and price to sales ratio is 0.93.
